首页> 外文OA文献 >Rationale and design of LUX-Head Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

【2h】

Rationale and design of LUX-Head Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类药物治疗后进展的复发和/或转移性头颈部鳞状细胞癌患者中的一项随机，III期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jean-Pascal H Machiels; Lisa F Licitra; Robert I Haddad; Makoto Tahara; Ezra EW Cohen;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy [J] . Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, BMC Cancer . 2014,第1期

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类药物治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机，III期临床试验
2. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy [J] . Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, BMC Cancer . 2014,第1期

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类药物治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机，III期临床试验
3. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial [J] . Machiels Jean-Pascal H., Haddad Robert I., Fayette Jerome, The lancet oncology . 2015,第5期

机译：阿法替尼vs甲氨蝶呤作为铂类疗法治疗后或复发的复发性或转移性头颈部鳞状细胞癌患者的二线治疗（LUX-Head＆Neck 1）：一项开放性，随机，3期试验
4. Interstitial photodynamic therapy in combination with Cetuximab for recurrent head and neck squamous cell carcinoma [C] . Nestor Rigual, Ambujakshan Dildeep, Gal Shafirstein Conference on photonic therapeutics and diagnostics IX . 2013

机译：间质性光动力疗法联合西妥昔单抗治疗复发性头颈部鳞状细胞癌
5. Inflammatory mechanisms of chemokine receptor 7 expression in metastatic squamous cell carcinoma of the head and neck (SCCHN). [D] . Mburu, Yvonne K. 2011

机译：趋化因子受体7在头颈部转移性鳞状细胞癌（SCCHN）中表达的炎症机制。
6. Rationale and design of LUX-Head Neck 1: a randomised Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy [O] . Jean-Pascal H Machiels, Lisa F Licitra, Robert I Haddad, 2014

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类疗法治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机III期临床试验
7. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy. [O] . Machiels, Jean-Pascal, Licitra, Lisa F, Haddad, Robert I, 2014

机译：LUX-Head＆Neck的原理和设计1：阿法替尼与甲氨蝶呤在铂类疗法治疗后复发和/或转移性头颈部鳞状细胞癌患者中进行的一项随机，III期临床试验。

Rationale and design of LUX-Head Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

著录项

相似文献

相关主题

期刊订阅